Inflammation in Heart Failure
Editat de Matthijs Blankesteijn, Raffaele Altaraen Limba Engleză Paperback – 5 dec 2014
- Presents updated information and research on the relevant inflammatory mediators of heart failure to aid in targeting future translational research as well as the improvement of early diagnosis and treatment
- Provides research into better understanding the different inflammatory mediators that signal the underlying diseases that potentially lead to heart failure
- Contains 20 years of research, offering a brief overview of the topic leading to current opinions on, and treatment of, heart failure
- Provides a structured, systematic and balanced overview of the role of inflammation in heart failure making it a useful resource for researchers and clinicians, as well as those studying cardiovascular diseases
Preț: 595.76 lei
Preț vechi: 796.13 lei
-25% Nou
Puncte Express: 894
Preț estimativ în valută:
114.03€ • 117.51$ • 96.27£
114.03€ • 117.51$ • 96.27£
Carte tipărită la comandă
Livrare economică 25 februarie-11 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128000397
ISBN-10: 0128000392
Pagini: 220
Ilustrații: Approx. 150 illustrations (150 in full color)
Dimensiuni: 216 x 276 x 14 mm
Greutate: 0.64 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128000392
Pagini: 220
Ilustrații: Approx. 150 illustrations (150 in full color)
Dimensiuni: 216 x 276 x 14 mm
Greutate: 0.64 kg
Editura: ELSEVIER SCIENCE
Public țintă
Researchers in the cardiovascular field and cardiologistsCuprins
Preface
Section 1 Pathophysiology of the inflammatory response in heart failure
Chapter 1: Inflammation in HFpEF
Chapter 2: Role of the innate immune system in ischemic heart failure
Chapter 3: The role of inflammation in myocardial infarction
Chapter 4: Crosstalk between inflammation and extracellular matrix
Chapter 5: Crosstalk between brain and inflammation
Chapter 6: Translation of animal models into clinical practice: application to heart failure
Section 2 Inflammatory biomarkers
Chapter 7: Inflammatory biomarkers in post-infarction heart failure and cardiac remodeling
Chapter 8: Technological aspects of measuring inflammatory markers
Chapter 9: Molecular imaging to identify the vulnerable plaque – From basic research to clinical practice
Section 3 Targeting of the inflammatory response
Chapter 10: Mineralcorticoid receptor antagonists
Chapter 11: PPARs as modulators of cardiac metabolism and inflammation
Chapter 12: Inflammatory modulation by statins and heart failure: From pharmacological data to clinical evidence
Chapter 13: Small but smart—microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing
Chapter 14: The role of cytokines in clinical heart failure
Section 1 Pathophysiology of the inflammatory response in heart failure
Chapter 1: Inflammation in HFpEF
Chapter 2: Role of the innate immune system in ischemic heart failure
Chapter 3: The role of inflammation in myocardial infarction
Chapter 4: Crosstalk between inflammation and extracellular matrix
Chapter 5: Crosstalk between brain and inflammation
Chapter 6: Translation of animal models into clinical practice: application to heart failure
Section 2 Inflammatory biomarkers
Chapter 7: Inflammatory biomarkers in post-infarction heart failure and cardiac remodeling
Chapter 8: Technological aspects of measuring inflammatory markers
Chapter 9: Molecular imaging to identify the vulnerable plaque – From basic research to clinical practice
Section 3 Targeting of the inflammatory response
Chapter 10: Mineralcorticoid receptor antagonists
Chapter 11: PPARs as modulators of cardiac metabolism and inflammation
Chapter 12: Inflammatory modulation by statins and heart failure: From pharmacological data to clinical evidence
Chapter 13: Small but smart—microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing
Chapter 14: The role of cytokines in clinical heart failure